Eisai Showcases Alzheimer’s Research at AAIC 2026 Meeting
TOKYO, June 29, 2026 Eisai Co., Ltd. has announced it will present more than 50 scientific presentations highlighting the...
Monoclonal Antibody
Advertisement
Star Therapeutics to Present Phase 1/2 VGA039 Data at ISTH 2026
SOUTH SAN FRANCISCO, Calif., June 26, 2026 Star Therapeutics announced it will present complete safety and efficacy data from...
Mediar Starts Phase 1 Trial of MTX-439 in CKD
BOSTON, Mass. | June 23, 2026 Mediar Therapeutics has announced that the first cohorts have been dosed in its...
Incyte Secures Japan Approval for Minjuvi in DLBCL Care
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
TuHURA Files IND for TBS-2025 in AML and Blood Cancers
TAMPA, Fla., June 15, 2026 TuHURA Biosciences, Inc. has announced the filing of an Investigational New Drug (IND) application...
Advertisements
Akeso Wins NMPA Approval for Gumokimab in Plaque Psoriasis
HONG KONG, June 11, 2026 Akeso, Inc. announced that China’s National Medical Products Administration (NMPA) has approved gumokimab (AK111,...
Sanofi Ends Phase 3 MOBILIZE Trial of Riliprubart in CIDP
PARIS, France, June 10, 2026 Sanofi announced that it will discontinue the Phase 3 MOBILIZE study evaluating riliprubart in...
Kelun-Biotech and Windward Bio Advance SKB378 in COPD
CHENGDU, China – June 9, 2026 Kelun-Biotech has announced that its partner Windward Bio has successfully dosed the first...
Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care
NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...
GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion
LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...
Advertisement
